Icon (ICLR) Change in Cash (2009 - 2026)
Icon's (ICLR) quarterly Change in Cash came in at $928.4 million in Q2 2026, up 137.81% year-over-year from $390.4 million in Q2 2025, and up 687.64% quarter-over-quarter from $117.9 million in Q1 2026.
Analysis
Icon (ICLR) Change in Cash (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Change in Cash for 18 consecutive years, with $928.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Cash rose 137.81% year-over-year to $928.4 million in Q2 2026; TTM through Jun 2026 was $2.2 billion, a 38.43% increase from a year earlier, with the FY2025 full-year figure at $647.3 million, up 254.33% from the prior year.
- Change in Cash was $928.4 million for Q2 2026 at Icon, up from $117.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $928.4 million in Q2 2026 and troughed at -$320.4 million in Q4 2022.
- A 5-year average of $269.9 million and a median of $291.6 million in 2023 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash soared 5535.16% in 2023 and sank 167.22% in 2025, its largest moves.
- Over 5 years, Change in Cash stood at -$320.4 million in 2022, then surged by 218.01% to $378.1 million in 2023, then surged by 42.5% to $538.8 million in 2024, then soared by 33.11% to $717.2 million in 2025, then climbed by 29.45% to $928.4 million in 2026.
- The last three Change in Cash figures came in at $928.4 million (Q2 2026), $117.9 million (Q1 2026), and $717.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -38.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -149.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 42.38 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.10 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.65 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 928.39 Mn |
| Mar 31, 2026 | 117.87 Mn |
| Dec 31, 2025 | 717.19 Mn |
| Sep 30, 2025 | 468.89 Mn |
| Jun 30, 2025 | 390.40 Mn |
| Mar 31, 2025 | -12.09 Mn |
| Dec 31, 2024 | 538.79 Mn |
| Sep 30, 2024 | 695.51 Mn |
| Jun 30, 2024 | 506.55 Mn |
| Mar 31, 2024 | 17.98 Mn |
| Dec 31, 2023 | 378.10 Mn |
| Sep 30, 2023 | 313.07 Mn |
| Jun 30, 2023 | 270.18 Mn |
| Mar 31, 2023 | -8.89 Mn |
| Dec 31, 2022 | -320.39 Mn |
| Sep 30, 2022 | -5.76 Mn |
| Jun 30, 2022 | 55.82 Mn |
| Mar 31, 2022 | -193.12 Mn |
| Dec 31, 2021 | 752.21 Mn |
| Sep 30, 2021 | -46.97 Mn |